Inside the Clinic: Treating AYA ALL - Episode 2

AYA ALL: Overview and Risk Stratification

, ,

Experts on acute lymphoblastic leukemia share their clinical experiences, describe high-risk features, and provide insights on risk stratification practices.

Current Time 0:00
Duration 5:38
Loaded: 0%
Stream Type LIVE
Remaining Time 5:38
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected
EP. 1: Clinical Scenario: A 23-Year-Old Male with AYA ALL
Now Viewing
EP. 2: AYA ALL: Overview and Risk Stratification
EP. 3: AYA ALL: Pediatric and Adult Inspired Regimens
EP. 4: AYA ALL: Role of Asparaginase Erwinia Chrysanthemi
EP. 5: Asparaginase Erwinia Chrysanthemi: Side Effects and Hypersensitivity Reactions
EP. 6: ALL AYA: Coordination of Care
EP. 7: Clinical Scenario of a 32-Year-Old Female with AYA ALL and the Role of Cytogenetics in AYA ALL
EP. 8: CALBG 10403 in AYA ALL
EP. 9: The Potential of Modified Treatment Regimens in AYA ALL
EP. 10: The Future of AYA ALL

Video content above is prompted by the following questions:

  • How is ALL risk stratified?
    • Which patient risk factors are considered?
    • Is there one standard model used?
    • What defines low-standard risk vs high risk?
x